Pulse Biosciences Cash from Financing (TTM) Insights

Pulse Biosciences Inc (PLSE)

7.35 -0.13 (-1.74%) USD | NASDAQ | Apr 18, 16:00

7.35 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	16.39M
September 30, 2023	15.57M
June 30, 2023	78.48M
March 31, 2023	79.57M
December 31, 2022	79.94M
September 30, 2022	79.41M
June 30, 2022	22.42M
March 31, 2022	11.46M
December 31, 2021	62.68M
September 30, 2021	63.67M
June 30, 2021	56.02M
March 31, 2021	81.78M
December 31, 2020	30.88M
September 30, 2020	30.45M

Date	Value
June 30, 2020	30.22M
March 31, 2020	-0.148M
December 31, 2019	0.082M
September 30, 2019	44.94M
June 30, 2019	45.14M
March 31, 2019	45.69M
December 31, 2018	45.50M
September 30, 2018	0.823M
June 30, 2018	30.43M
March 31, 2018	30.71M
December 31, 2017	35.38M
September 30, 2017	35.19M
June 30, 2017	5.186M
March 31, 2017	25.89M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.148M

Minimum

Mar 2020

81.78M

Maximum

Mar 2021

43.63M

Average

44.94M

Median

Sep 2019

Cash from Financing (TTM) Benchmarks